← Genmab
What podcasts say about Genmab
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Genmab
2 statements · 2 positive
GenmAb exceeded revenue and profit expectations and raised its annual outlook.
“GenmAb makes antibody therapeutics, so reported better than expected revenue, better than expected profit for the second quarter and it also boosted its outlook for the year.”
Open the episode · Kingspan Soars, Daimler Truck Slumps, Genmab JumpsListen at 3:30
GenmAb’s lymphoma program could represent a $600 million opportunity in 2035.
“that could be a $600 million commercial opportunity in 2035, according to Bloomberg Intelligence”
Open the episode · Kingspan Soars, Daimler Truck Slumps, Genmab JumpsListen at 4:02
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.